Kan Biosys Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 2.49 Cr
as on 16-11-2024
- Company Age 19 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 61.08 Cr
as on 16-11-2024
- Satisfied Charges ₹ 9.74 Cr
as on 16-11-2024
- Revenue 16.41%
(FY 2023)
- Profit 216.16%
(FY 2023)
- Ebitda 23.24%
(FY 2023)
- Net Worth 1390.78%
(FY 2023)
- Total Assets 256.25%
(FY 2023)
About Kan Biosys
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 2.49 Cr.
The company currently has active open charges totaling ₹61.08 Cr. The company has closed loans amounting to ₹9.74 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sandeepa Kanitkar, Eric Gantoy, and Nicolas Fillon serve as directors at the Company.
- CIN/LLPIN
U24239PN2005PTC020704
- Company No.
020704
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 May 2005
- Date of AGM
25 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Kan Biosys Private Limited offer?
Kan Biosys Private Limited offers a wide range of products and services, including Fertilizers and Soil Additives, Bio Fertilizers, Fertilizer, Insecticides and Pesticides, Bio Insecticides, Seeds and Plant Saplings, Seeds, Bacillus Thuringiensis, Insecticides, Biofungicides.
Who are the key members and board of directors at Kan Biosys?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sandeepa Kanitkar  | Managing Director | 09-May-2005 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Eric Gantoy  | Nominee Director | Current | |
| Nicolas Fillon | Nominee Director | Current |
Financial Performance and Corporate Structure Insights of Kan Biosys.
Kan Biosys Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 16.41% increase. The company also saw a substantial improvement in profitability, with a 216.16% increase in profit. The company's net worth Soared by an impressive increase of 1390.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kan Biosys?
In 2023, Kan Biosys had a promoter holding of 98.58% and a public holding of 1.42%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Biological Agri Solutions Association Of IndiaActive 5 years 6 months
Sandeepa Kanitkar is a mutual person
- Krishimitra Bio-Products Private LimitedActive 31 years 10 months
Sandeepa Kanitkar is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 05 Jun 2024 | ₹38.70 Cr | Open |
Others Creation Date: 27 Mar 2018 | ₹1.98 Cr | Open |
Hdfc Bank Limited Creation Date: 21 Feb 2018 | ₹20.40 Cr | Open |
How Many Employees Work at Kan Biosys?
Kan Biosys has a workforce of 149 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kan Biosys, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kan Biosys's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
